Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jing-Jin Electric Technologies
688280
5
Hangzhou Anysoft Information Technology
300571
US Stock MarketDetailed Quotes
ACET Adicet Bio
- 0.6335
- +0.0136+2.19%
Trading Apr 29 14:00 ET
52.38MMarket Cap-0.48P/E (TTM)
0.6335High0.6200Low104.48KVolume0.6200Open0.6199Pre Close65.34KTurnover0.17%Turnover RatioLossP/E (Static)82.69MShares1.865052wk High0.28P/B38.83MFloat Cap0.447152wk Low--Dividend TTM61.29MShs Float214.3613Historical High--Div YieldTTM2.18%Amplitude0.4471Historical Low0.6250Avg Price1Lot Size
About Adicet Bio Company
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Company Profile
SymbolACET
Company NameAdicet Bio
Listing DateJan 26, 2018
Issue Price15.00
Founded2014
CEOMr. Chen Schor, M.B.A.
MarketNASDAQ
Employees152
Fiscal Year Ends12-31
Address131 Dartmouth Street,3rd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02116
Phone1-650-503-9095
Websitehttp://www.adicetbio.com
Company Executives
- Name
- Position
- Salary
- Chen Schor, M.B.A.
- Director, Chief Executive Officer and President
- --
- Julia D. Maltzman
- Chief Medical Officer
- --
- Nick Harvey
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Donald Healey, PhD
- Chief Technology Officer
- --
- Dr. Blake Aftab, PhD
- Chief Scientific Officer
- --
- Katie Peng
- Independent Director
- --
- Steve Dubin, J.D.
- Independent Director
- --
- Dr. Lloyd Klickstein, M.D.,PhD
- Independent Director
- --
- Dr. Jeffrey A. Chodakewitz, M.D.
- Independent Director
- --
- Dr. Aya Jakobovits, PhD
- Independent Director
- --
- Dr. Andrew Sinclair, PhD
- Independent Director
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now